2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Wednesday, June 7, 2017

1:15pm-2:45pm: Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

D. Weintraub (Philadelphia, PA, USA)

Cognitive Disorders · Exhibit Hall C

1:15pm-2:45pm: Myoclonus in the Elderly: Retrospective Analysis of Clinical and Electrophysiological characteristics of patients referred to an electrophysiology laboratory

M. Kiziltan, A. Gunduz, M. Tutuncu, U. Uygunoglu, A. Sifoglu, S. Ertan, H. Apaydin, M. Bozluolcay, S. Saip, G. Kiziltan (Istanbul, Turkey)

Myoclonus · Exhibit Hall C

1:15pm-2:45pm: Network for parallel gamma synchronizations during upper limb movement

G. Tamas, A. Anwar, G. Deuschl, J. Raethjen, S. Groppa, M. Muthuraman (Budapest, Hungary)

Neurophysiology (Non-PD) · Exhibit Hall C

1:15pm-2:45pm: Neurodegenerative biomarker abnormality frequency in idiopathic REM sleep behavior disorder

A. Boeve, S. McCord, P. Timm, D. Sandness, N. Commers, E. Duwell, G. Tabatabai, S. McCarter, M. Junna, M. Lipford, M. Tippmann-Peikert, B. Boeve, M. Silber, E. St. Louis (Rochester, MN, USA)

Parkinson's Disease: Cognition · Exhibit Hall C

1:15pm-2:45pm: Neuroferritinopathy pedigree in 2 families from India

J. Kaur, G. Singh, B. Paul (Ludhiana, India)

Choreas (Non-Huntington’s Disease) · Exhibit Hall C

1:15pm-2:45pm: Neurofilament light chain levels in cerebrospinal fluid do not discriminate between patients with prion disease and mimics

B. Roeben, E. Stransky, K. Brockmann, R. Schüle, W. Maetzler, T. Gasser, G. Machetanz (Tübingen, Germany)

Cognitive Disorders · Exhibit Hall C

1:15pm-2:45pm: Neuroimaging studies in familial forms of Parkinson’s disease: A systematic review

J. Fernandez Bonfante, G. Pagano, M. Politis (London, United Kingdom)

Parkinson's Disease: Genetics · Exhibit Hall C

1:15pm-2:45pm: Neurological examination of motor Functional Neurological Disorders: an evidence-based review towards the development of consensus guidelines from the Committee on Research of the ANPA

S. Aybek, D. Perez, W.C. LaFrance, C. Stephen, R. Shura, S. Glass, S. Ducharme, V. Voon (Bern, Switzerland)

Phenomenology and Clinical Assessment Of Movement Disorders · Exhibit Hall C

1:15pm-2:45pm: Neuromelanin Magnetic Resonance Imaging of the Substatia Nigra in LRRK2 -related Parkinson’s disease

L. Correia Guedes, S. Reimão, P. Paulino, R. Nunes, R. Bouça, D. Abreu, N. Gonçalves, T. Soares, M. Fabbri, C. Godinho, P. Lobo, D. Neutel, M. Quadri, M. Coelho, M.M. Rosa, J. Campos, T. Outeiro, C. Sampaio, V. Bonifati, J. Ferreira (Lisbon, Portugal)

Parkinson's Disease: Genetics · Exhibit Hall C

1:15pm-2:45pm: Neuroprotection of indole-derivative compound NC001-8 in Parkinson disease cell model by regulatory of NRF2 pathway

P.-C. Wei (Tao-Yuan, Taiwan)

Parkinson's Disease: Genetics · Exhibit Hall C